REFERENCES
1. Zahariev OJ, Bunduc S, Kovács A, et al. Risk factors for diabetes mellitus after acute pancreatitis: a systematic review and meta-analysis. Front Med. 2023;10:1257222.
2. Ba DM, Chinchilli VM, Cozzi AM, Bradley DP, Pichardo-Lowden AR. Association of pancreatitis with risk of diabetes: analysis of real-world data. Front Clin Diabetes Healthc. 2023;4:1326239.
3. Pahomeanu MR, Ojog D, Nițu DT, Diaconu IȘ, Nayyerani H, Negreanu L. Acute pancreatitis and type 2 diabetes mellitus: the chicken-egg paradox-a seven-year experience of a large tertiary center. J Clin Med. 2024;13:1213.
4. Woodmansey C, McGovern AP, McCullough KA, et al. Incidence, demographics, and clinical characteristics of diabetes of the exocrine pancreas (type 3c): a retrospective cohort study. Diabetes Care. 2017;40:1486-93.
5. García-Compeán D, Jiménez-Rodríguez AR, Muñoz-Ayala JM, González-González JA, Maldonado-Garza HJ, Villarreal-Pérez JZ. Post-acute pancreatitis diabetes: a complication waiting for more recognition and understanding. World J Gastroenterol. 2023;29:4405-15.
6. Lonardo A, Singal AK, Osna N, Kharbanda KK. Effect of cofactors on NAFLD/NASH and MAFLD. A paradigm illustrating the pathomechanics of organ dysfunction. Metab Target Organ Damage. 2022;2:12.
7. Corbett JA, Sweetland MA, Wang JL, Lancaster JR Jr, McDaniel ML. Nitric oxide mediates cytokine-induced inhibition of insulin secretion by human islets of Langerhans. Proc Natl Acad Sci U S A. 1993;90:1731-5.
8. Böni-Schnetzler M, Boller S, Debray S, et al. Free fatty acids induce a proinflammatory response in islets via the abundantly expressed interleukin-1 receptor I. Endocrinology. 2009;150:5218-29.
9. Zhang AMY, Xia YH, Lin JSH, et al. Hyperinsulinemia acts via acinar insulin receptors to initiate pancreatic cancer by increasing digestive enzyme production and inflammation. Cell Metab. 2023;35:2119-35.e5.
10. Zhong L, Liu J, Liu S, Tan G. Correlation between pancreatic cancer and metabolic syndrome: a systematic review and meta-analysis. Front Endocrinol. 2023;14:1116582.
11. DiNorcia J, Lee MK, Moroziewicz DN, et al. RAGE gene deletion inhibits the development and progression of ductal neoplasia and prolongs survival in a murine model of pancreatic cancer. J Gastrointest Surg. 2012;16:104-12; discussion 112.
12. UK Biobank Whole-Genome Sequencing Consortium. Whole-genome sequencing of 490,640 UK Biobank participants. Nature. 2025;645:692-701.
13. Mahajan A, Taliun D, Thurner M, et al. Fine-mapping type 2 diabetes loci to single-variant resolution using high-density imputation and islet-specific epigenome maps. Nat Genet. 2018;50:1505-13.
14. Dou C, Liu D, Kong L, et al. Shared genetic architecture of type 2 diabetes with muscle mass and function and frailty reveals comorbidity etiology and pleiotropic druggable targets. Metabolism. 2025;164:156112.
15. Ray D, Chatterjee N. A powerful method for pleiotropic analysis under composite null hypothesis identifies novel shared loci between Type 2 Diabetes and Prostate Cancer. PLoS Genet. 2020;16:e1009218.
16. Watanabe K, Taskesen E, van Bochoven A, Posthuma D. Functional mapping and annotation of genetic associations with FUMA. Nat Commun. 2017;8:1826.
17. Burgess S, Thompson SG; CRP CHD Genetics Collaboration. Avoiding bias from weak instruments in Mendelian randomization studies. Int J Epidemiol. 2011;40:755-64.
18. Papadimitriou N, Dimou N, Tsilidis KK, et al. Physical activity and risks of breast and colorectal cancer: a Mendelian randomisation analysis. Nat Commun. 2020;11:597.
19. Bowden J, Davey Smith G, Haycock PC, Burgess S. Consistent estimation in Mendelian randomization with some invalid instruments using a weighted median estimator. Genet Epidemiol. 2016;40:304-14.
20. Bowden J, Davey Smith G, Burgess S. Mendelian randomization with invalid instruments: effect estimation and bias detection through Egger regression. Int J Epidemiol. 2015;44:512-25.
21. Del Bosque-Plata L, Martínez-Martínez E, Espinoza-Camacho MÁ, Gragnoli C. The role of TCF7L2 in type 2 diabetes. Diabetes. 2021;70:1220-8.
22. Rasmussen KL, Frikke-Schmidt R. The current state of apolipoprotein E in dyslipidemia. Curr Opin Lipidol. 2024;35:78-84.
23. Phu TA, Ng M, Vu NK, Gao AS, Raffai RL. ApoE expression in macrophages communicates immunometabolic signaling that controls hyperlipidemia-driven hematopoiesis & inflammation via extracellular vesicles. J Extracell Vesicles. 2023;12:e12345.
24. Keenan SN, Watt MJ, Montgomery MK. Inter-organelle communication in the pathogenesis of mitochondrial dysfunction and insulin resistance. Curr Diab Rep. 2020;20:20.
25. Chen F, Xu K, Han Y, et al. Mitochondrial dysfunction in pancreatic acinar cells: mechanisms and therapeutic strategies in acute pancreatitis. Front Immunol. 2024;15:1503087.
26. Yang NV, Chao JY, Garton KA, et al. TOMM40 regulates hepatocellular and plasma lipid metabolism via an LXR-dependent pathway. Mol Metab. 2024;90:102056.
27. Ma Y, Zuo S, Lo T, et al. Genetic variations in GCKR and PNPLA3 regulate metabolic balance across the liver. Diabetes. 2025;74:1300-9.
